表皮生长因子在皮肤科临床应用的安全性研究进展

[1]

ZHOU Yanjun, WANG Ying, LIU Xiaoqin, LI Fengxiang, YANG Xiaolong, XIONG Xincai. Acneiform drug eruption caused by afatinib: two cases report [J]. China Journal of Leprosy and Skin Diseases, 2022, 38(2): 116-118.

[2]

ZHENG Yujie, LU Yan. Application of laser capture microdissection in dermatology [J]. China Journal of Leprosy and Skin Diseases, 2022, 38(2): 132-134.

[3]

WU Xiaoxiao, HUAI Pengcheng, YE Xing, ZHU Jiaming, LIU Yijun, ZHAO Wei, CHU Tongsheng, LIU Dianchang, LIU Jian, ZHANG Furen. Study on leprosy prevention and control strategies in low epidemic state —based on leprosy symptom monitoring by member units of Shandong dermatology departments alliance [J]. China Journal of Leprosy and Skin Diseases, 2022, 38(1): 3-7.

[4]

XIONG Qiying, YE Ruixian, ZHANG Xibao. Research on small molecular targeted drugs in dermatology [J]. China Journal of Leprosy and Skin Diseases, 2022, 38(1): 65-70.

[5]

ZHOU Xingli, ZHAN Tongying, LI Wei. Application of azathioprine in dermatology [J]. China Journal of Leprosy and Skin Diseases, 2021, 37(11): 739-743.

[6]

YE Ruixian, LIU Huanyan, XIONG Qiying, DONG Liangjiao, XU Xiao, ZHANG Xibao. Application of methotrexate in dermatology [J]. China Journal of Leprosy and Skin Diseases, 2020, 36(6): 378-381.

[7]

YANG Baoqi, ZHANG Zhaoxia, CHEN Mingfei, WANG Na, YAN Xiaoxiao, YANG Qing, PAN Futang, WANG Guangjin, DU Donghong, WU Mei, SHI Zhongxiang, ZHANG Furen. Treatment of pemphigus with rituximab: report of six cases and literature review [J]. China Journal of Leprosy and Skin Diseases, 2020, 36(12): 718-721.

[8]

WANG Wenzhu, HE Yanyan, XU Haoxiang. Update of epidermal growth factor receptor signaling pathway in the pathogenesis of related skin diseases [J]. China Journal of Leprosy and Skin Diseases, 2020, 36(11): 697-700.

[9]

ZHAO Qing, LIU Hong, ZHANG Furen. Dapsone in dermatology [J]. China Journal of Leprosy and Skin Diseases, 2020, 36(10): 621-625.

[10]

REN Kaixuan, XIA Yumin. Effect of cold atmospheric plasma exhibits biological on cutaneous keratinocytes [J]. China Journal of Leprosy and Skin Diseases, 2019, 35(7): 441-444.

[11]

QIAN Jiali, HE Jingyan, SUN Liyun. Efficacy and safety of three-times dose of Ebastine in the treatment of mild to moderate atopic dermatitis [J]. China Journal of Leprosy and Skin Diseases, 2019, 35(2): 70-72.

[12]

CHEN Jinguang, CAI Tianguo, LIN Lanying, ZHENG Changzhu.. The role of antimicrobial peptide LL-37 in dermatology [J]. China Journal of Leprosy and Skin Diseases, 2018, 34(2): 122-124.

[13]

SHANG Shuxian, YAN Yan, WU Xiaochu, LI Qi, YANG Chenhong.

[14]

FANG Xiaoxian, MA Guitao, YUAN Dinggui. HIV detection analysis in patients with skin and venereal disease in Shantou from 2012 to 2015 [J]. China Journal of Leprosy and Skin Diseases, 2016, 32(9): 537-540.

PDF (PC)